Patents by Inventor Maryam Rashidi

Maryam Rashidi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Soluble Mediator
    Publication number: 20200078440
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Application
    Filed: August 21, 2019
    Publication date: March 12, 2020
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang, Maryam Rashidi
  • Method of treating sepsis by administering a soluble CD52 glycoprotein
    Patent number: 9778269
    Abstract: The present disclosure relates to the use of a soluble CD52 glycoprotein in treating diseases regulated by effector T-cells, for example sepsis or multiple sclerosis. The present disclosure also relates to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: October 3, 2017
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Leonard Charles Harrison, Maryam Rashidi, Yuxia Zhang
  • Soluble Mediator
    Publication number: 20170232061
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Application
    Filed: December 19, 2016
    Publication date: August 17, 2017
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang, Maryam Rashidi
  • Soluble Mediator
    Publication number: 20150259412
    Abstract: The present disclosure relates to the use of a soluble CD52 glycoprotein in treating diseases regulated by effector T-cells, for example sepsis or multiple sclerosis. The present disclosure also relates to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Application
    Filed: March 25, 2013
    Publication date: September 17, 2015
    Inventors: Leonard Charles Harrison, Maryam Rashidi, Yuxia Zhang
  • Soluble Mediator
    Publication number: 20140308209
    Abstract: The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
    Type: Application
    Filed: November 15, 2012
    Publication date: October 16, 2014
    Inventors: Esther Bandala Sanchez, James Dromey, Leonard Charles Harrison, Yuxia Zhang, Maryam Rashidi